Does EDOXABAN Cause Epistaxis? 205 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 205 reports of Epistaxis have been filed in association with EDOXABAN (SAVAYSA). This represents 2.5% of all adverse event reports for EDOXABAN.
205
Reports of Epistaxis with EDOXABAN
2.5%
of all EDOXABAN reports
18
Deaths
101
Hospitalizations
How Dangerous Is Epistaxis From EDOXABAN?
Of the 205 reports, 18 (8.8%) resulted in death, 101 (49.3%) required hospitalization, and 16 (7.8%) were considered life-threatening.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for EDOXABAN.
What Other Side Effects Does EDOXABAN Cause?
Anaemia (663)
Cerebral infarction (419)
Gastrointestinal haemorrhage (378)
Renal impairment (359)
Cerebrovascular accident (337)
Dyspnoea (331)
General physical health deterioration (315)
Haematuria (312)
Fall (298)
Cardiac failure (272)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which EDOXABAN Alternatives Have Lower Epistaxis Risk?
EDOXABAN vs EDOXABAN TOSILATE
EDOXABAN vs EFALIZUMAB
EDOXABAN vs EFANESOCTOCOG ALFA
EDOXABAN vs EFAVIRENZ
EDOXABAN vs EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL